NIAID

The candidate for the HIV vaccine does not adequately protect women from HIV infection

NIH launches study of additional dose of COVID-19 vaccine in people with autoimmune disease

NIH testing of anti-CD14 antibody to treat COVID-19 respiratory diseases begins

NIH experts discuss post-acute COVID-19

NIH experts call for accelerated research to address concurrent HIV and COVID-19 pandemics

NIH and BARDA Statement on FDA Emergency Use Authorization for Janssen COVID-19 Vaccine

NIH experts discuss viral variants of SARS-CoV-2

Four possible COVID-19 therapeutic products enter phase 2/3 testing in the NIH ACTIV-2 trial

The intranasal flu vaccine stimulates a strong immune response in the phase 1 study

Janssen Investigational COVID-19 Vaccine: Provisional Analysis of Published Phase 3 Clinical Data